Sumpena, E., Vogiatzi, I., Patel, A., Walker, H., Mahns, J., Redd, R., Armand, P., Merryman, R., Murakami, M. (2025). Immune population changes after glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with follicular lymphoma and marginal zone lymphoma. Blood. https://doi.org/10.1182/blood-2025-5344